Ryan Preblick
Director of Finance/CFO bij INDIVIOR PLC
Vermogen: 1 M $ op 31-03-2024
Actieve functies van Ryan Preblick
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INDIVIOR PLC | Director of Finance/CFO | 29-06-2020 | - |
| Director/Board Member | 20-11-2020 | - | |
| Comptroller/Controller/Auditor | 01-01-2012 | 01-01-2020 | |
| Corporate Officer/Principal | 01-01-2020 | 29-06-2020 | |
| OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | - | - |
| Corporate Secretary | - | - | |
| Treasurer | - | - |
Loopbaan van Ryan Preblick
Opleiding van Ryan Preblick
| The Pennsylvania State University | Undergraduate Degree |
| University of Richmond | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INDIVIOR PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Beurs
- Insiders
- Ryan Preblick
- Ervaring
